Concepedia

Publication | Open Access

A Randomized Phase 2 Study of Long-Acting TransCon GH vs Daily GH in Childhood GH Deficiency

DOIFull Paper Access

52

Citations

13

References

2017

Year

Pierre Chatelain, O. A. Malievskiy, Klaudziya Radziuk, Magdy Abdou, Elpis Vlachopapadopoulou, Yulia Skorodok, Valentina Peterkova, Jonathan A. Leff, Michael Beckert
The Journal of Clinical Endocrinology & Metabolism

Abstract

The results suggest that long-acting TransCon GH is comparable to daily Genotropin for GH (pharmacokinetics) and IGF-1 (pharmacodynamics) levels, safety, and efficacy and support advancement into phase 3 development.

References

YearCitations

Page 1